Related Experiment Video

Updated: Jun 16, 2026

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

[Recommendations for the management of influenza in pediatrics (2009-2010).]

J Marès1, C Rodrigo, D Moreno-Pérez

  • 1Comité Asesor de Vacunas (CAV), España.

Anales De Pediatria
|February 6, 2010
PubMed

Insights

Pediatric influenza management guidelines for the 2009-2010 season emphasize clinical suspicion for diagnosis and focus on antiviral treatment only for severe cases. Vaccination is recommended for high-risk children to combat influenza A H1N1.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • The 2009 A H1N1 influenza pandemic prompted specific action plans globally.
  • Pediatric influenza management requires tailored recommendations for each season.

Purpose of the Study:

  • To provide recommendations for the management of influenza in children for the 2009-2010 season.
  • To outline risk factors, clinical course, and treatment strategies for pediatric influenza, including A H1N1.

Main Methods:

  • Clinical guidelines based on expert consensus.
  • Review of existing data on influenza A H1N1 and seasonal influenza in children.

Main Results:

  • Influenza A H1N1 shares similar risk factors, clinical course, and severity with seasonal influenza in pediatric patients.
  • Diagnosis is primarily clinical; antiviral treatment is reserved for severe cases or complications.
  • Hygiene and isolation measures are crucial for reducing transmission.

Conclusions:

  • Referral and hospital admission criteria should be based on clinical severity, not viral subtype.
  • Antiviral treatment is not routinely recommended for uncomplicated pediatric influenza.
  • Influenza vaccination, for both seasonal and A H1N1 strains, should prioritize children with risk factors.

More Related Videos

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B05:38

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B

Published on: January 30, 2017

Influenza A Virus Studies in a Mouse Model of Infection10:44

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...